ExploreWatchlistsPricing
  1. JP-listed companies
  2. JMS CO.,LTD.
  3. Financials
  4. Gross profit

JMS CO.,LTD. (7702)

Market cap
¥10.6B
P/E ratio
17.5x
JMS manufactures and sells medical devices and pharmaceuticals globally, serving healthcare markets across Asia, Europe and the Americas.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndGross profit (Million JPY)YoY (%)
Mar 31, 202615,355-3.57%
Mar 31, 202515,924+12.98%
Mar 31, 202414,094-3.43%
Mar 31, 202314,594+2.28%
Mar 31, 202214,269-5.47%
Mar 31, 202115,095-3.47%
Mar 31, 202015,638+5.53%
Mar 31, 201914,818+3.75%
Mar 31, 201814,282-1.06%
Mar 31, 201714,435-2.90%
Mar 31, 201614,866+10.51%
Mar 31, 201513,452

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat